Brian Stuglik is the founder of Verastem Oncology. Verastem Oncology has raised $16M in total funding. Based in Needham, Massachusetts.
Brian Stuglik served as the Chief Executive Officer of Verastem Oncology from 2019 through 2023. Verastem Oncology is a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients. Prior to his role as CEO, he had a 30-year career in oncology pharmaceuticals, spending the majority of it at Eli Lilly and Company, where he was Global Vice President and Chief Marketing Officer, Oncology Global Marketing.
Full founder directory · Investor directory · Company funding database · Fundraising library